Pharmaceutical Industry
-
{
- All
- News
- Videos
-
Children May Be More Vulnerable To Cancer-Causing Chemicals In Water And Medicines: Study
The study focuses on a chemical called NDMA (N-nitrosodimethylamine), which can be present in polluted water, processed foods, and some medications. This chemical has long been known to be potentially cancer-causing.
-
India Strengthens Pharmaceutical Sector, Shifts Focus To Innovation-Led Drug Development: Experts
New Delhi, April 14 (IANS) While India has built strong foundations in pharmaceuticals, the next phase of growth will require bold investments, deeper ecosystem collaboration, and a shift towards innovation-led development to position the country as
-
From Pharmacy Of World To Innovation Hub: PM Modi Bats For India's Pharmaceutical Leap
New Delhi, April 14 (IANS) Prime Minister Narendra Modi on Tuesday said that India’s pharma sector is moving up from the pharmacy of the world to a hub of innovation.
-
India To Lead Global Pharma Landscape With Innovation-Driven Approach: Minister
India aims to lead global pharma with focus on biologics, biosimilars, and specialty medicines, says Health Minister JP Nadda.
-
Health Ministry Mulls Ban On Cough Syrups For Children Under 2 Years: Report
New Delhi, April 11 (IANS) Health Ministry is reportedly considering banning prescriptions of paediatric cough syrups for children under two years and discouraging their use for those under five.
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
India Pharmaceutical Sector Aims To Make India A Global Innovation Hub In 2026
New Delhi, March 30 (IANS) India’s pharmaceutical sector is set to take a major step towards becoming an innovation-driven global powerhouse, as India Pharma 2026 aims to accelerate the industry’s transition from volume-based growth to value and rese
-
What Are Semaglutide Generics? Here's Why They Matter More In India Now
Semaglutide works by imitating the natural hormone glucagon-like peptide-1 (GLP-1), which plays a key role in managing blood sugar.
-
Stock Market Highlights: Markets End In Green As Wall Street, Asian Peers Edge Higher
Sensex Today | Nifty 50 | Stock Market Highlights: GIFT Nifty indicated another positive start for Nifty50 and the Sensex.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
India-US Trade Pact To Open $30 Trillion Market For Indian Exporters: Piyush Goyal
The India-US trade pact will open a $30 trillion market for Indian exporters, especially MSMEs, farmers and fishermen, Commerce and Industry Minister Piyush Goyal said.
-
Healthcare And Pharmaceutical Wishlist For Union Budget 2026: Industry Insiders Seek Key Reforms
India is all set to witness the announcement of Union budget 2026-27. In this article, we explore what healthcare and pharma stakeholders are expecting from the Government to make healthcare delivery robust.
-
India-EU Trade Pact Explained: $572 Billion Boost To Indian Pharma, MedTech Industry
The India-EU Free Trade Agreement opens access to the European Union's $572.3 billion pharmaceuticals and medical devices market, boosting India's pharma sector, employment, MSMEs and global supply chain integration, according to the government.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Children May Be More Vulnerable To Cancer-Causing Chemicals In Water And Medicines: Study
The study focuses on a chemical called NDMA (N-nitrosodimethylamine), which can be present in polluted water, processed foods, and some medications. This chemical has long been known to be potentially cancer-causing.
-
India Strengthens Pharmaceutical Sector, Shifts Focus To Innovation-Led Drug Development: Experts
New Delhi, April 14 (IANS) While India has built strong foundations in pharmaceuticals, the next phase of growth will require bold investments, deeper ecosystem collaboration, and a shift towards innovation-led development to position the country as
-
From Pharmacy Of World To Innovation Hub: PM Modi Bats For India's Pharmaceutical Leap
New Delhi, April 14 (IANS) Prime Minister Narendra Modi on Tuesday said that India’s pharma sector is moving up from the pharmacy of the world to a hub of innovation.
-
India To Lead Global Pharma Landscape With Innovation-Driven Approach: Minister
India aims to lead global pharma with focus on biologics, biosimilars, and specialty medicines, says Health Minister JP Nadda.
-
Health Ministry Mulls Ban On Cough Syrups For Children Under 2 Years: Report
New Delhi, April 11 (IANS) Health Ministry is reportedly considering banning prescriptions of paediatric cough syrups for children under two years and discouraging their use for those under five.
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
India Pharmaceutical Sector Aims To Make India A Global Innovation Hub In 2026
New Delhi, March 30 (IANS) India’s pharmaceutical sector is set to take a major step towards becoming an innovation-driven global powerhouse, as India Pharma 2026 aims to accelerate the industry’s transition from volume-based growth to value and rese
-
What Are Semaglutide Generics? Here's Why They Matter More In India Now
Semaglutide works by imitating the natural hormone glucagon-like peptide-1 (GLP-1), which plays a key role in managing blood sugar.
-
Stock Market Highlights: Markets End In Green As Wall Street, Asian Peers Edge Higher
Sensex Today | Nifty 50 | Stock Market Highlights: GIFT Nifty indicated another positive start for Nifty50 and the Sensex.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
India-US Trade Pact To Open $30 Trillion Market For Indian Exporters: Piyush Goyal
The India-US trade pact will open a $30 trillion market for Indian exporters, especially MSMEs, farmers and fishermen, Commerce and Industry Minister Piyush Goyal said.
-
Healthcare And Pharmaceutical Wishlist For Union Budget 2026: Industry Insiders Seek Key Reforms
India is all set to witness the announcement of Union budget 2026-27. In this article, we explore what healthcare and pharma stakeholders are expecting from the Government to make healthcare delivery robust.
-
India-EU Trade Pact Explained: $572 Billion Boost To Indian Pharma, MedTech Industry
The India-EU Free Trade Agreement opens access to the European Union's $572.3 billion pharmaceuticals and medical devices market, boosting India's pharma sector, employment, MSMEs and global supply chain integration, according to the government.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
